CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $12,333,473 | -45.4% | 321,017 | -67.1% | 4.31% | -42.2% |
| Q1 2023 | $22,594,886 | +5.4% | 976,021 | +19.3% | 7.46% | -11.3% |
| Q4 2022 | $21,432,517 | +33.9% | 818,035 | +0.5% | 8.40% | +88.2% |
| Q3 2022 | $16,003,000 | -2.4% | 813,998 | -13.2% | 4.47% | -35.4% |
| Q2 2022 | $16,398,000 | +18.6% | 937,568 | +10.9% | 6.91% | +212.5% |
| Q1 2022 | $13,827,000 | +52.7% | 845,155 | +52.2% | 2.21% | -32.7% |
| Q4 2021 | $9,055,000 | +854.2% | 555,155 | +646.8% | 3.29% | +1270.0% |
| Q3 2021 | $949,000 | -66.4% | 74,341 | -62.8% | 0.24% | -76.3% |
| Q2 2021 | $2,824,000 | +3.8% | 200,000 | +14.3% | 1.01% | +9.4% |
| Q1 2021 | $2,720,000 | +14.3% | 175,000 | +16.7% | 0.92% | -26.7% |
| Q4 2020 | $2,379,000 | – | 150,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |